265 related articles for article (PubMed ID: 33936646)
1. Rectovaginal fistula in a cervical cancer patient treated with sequential radiotherapy and bevacizumab: A dose-volume analysis.
Tomizawa K; Ando K; Shimada H; Kaminuma T; Murata K; Oike T; Ohno T
Clin Case Rep; 2021 Apr; 9(4):2099-2104. PubMed ID: 33936646
[TBL] [Abstract][Full Text] [Related]
2. Fatal rectovaginal fistula in post-radiotherapy locally advanced cervical cancer patients.
Wu CY; Tseng LM; Chen HH; Hsieh CH; Hsiao SM
Taiwan J Obstet Gynecol; 2022 Nov; 61(6):1069-1072. PubMed ID: 36427977
[TBL] [Abstract][Full Text] [Related]
3. Use of bevacizumab before or after radiotherapy increases the risk of fistula formation in patients with cervical cancer.
Kim N; Choi SH; Chang JS; Kim YT; Kim SW; Kim GM; Kim YB
Int J Gynecol Cancer; 2021 Jan; 31(1):59-65. PubMed ID: 33273018
[TBL] [Abstract][Full Text] [Related]
4. Can we predict vesicovaginal or rectovaginal fistula formation in patients with stage IVA cervical cancer?
Biewenga P; Mutsaerts MA; Stalpers LJ; Buist MR; Schilthuis MS; van der Velden J
Int J Gynecol Cancer; 2010 Apr; 20(3):471-5. PubMed ID: 20375815
[TBL] [Abstract][Full Text] [Related]
5. Hypoalbuminemia is a Predictive Factor for Fistula Formation in Recurrent Cervical Cancer.
Palavalli Parsons LH; Roane B; Manders DB; Richardson DL; Kehoe SM; Carlson M; Miller DS; Lea JS
Am J Clin Oncol; 2018 Oct; 41(10):933-937. PubMed ID: 28817390
[TBL] [Abstract][Full Text] [Related]
6. Incidence of fistula occurrence in patients with cervical cancer treated with bevacizumab: data from real-world clinical practice.
Sugiyama T; Katsumata N; Toita T; Ura M; Shimizu A; Kamijima S; Aoki D
Int J Clin Oncol; 2022 Sep; 27(9):1517-1528. PubMed ID: 35760943
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous rectovaginal fistula during bevacizumab therapy for ovarian cancer: a case report.
Chéreau E; Stefanescu D; Selle F; Rouzier R; Daraï E
Am J Obstet Gynecol; 2009 Jan; 200(1):e15-6. PubMed ID: 19121652
[TBL] [Abstract][Full Text] [Related]
8. Bevacizumab plus microtubule targeting agents in heavily pre-treated ovarian cancer patients: a retrospective study.
Asmane I; Kurtz JE; Bajard A; Guastalla JP; Meeus P; Tredan O; Labidi Galy I; Moullet I; Ardisson P; Vincent L; Coeffic D; Dufresne A; Bergerat JP; Ray-Coquard I
Bull Cancer; 2011 Oct; 98(9):80-9. PubMed ID: 21926034
[TBL] [Abstract][Full Text] [Related]
9. Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer.
Redondo A; Colombo N; McCormack M; Dreosti L; Nogueira-Rodrigues A; Scambia G; Lorusso D; Joly F; Schenker M; Ruff P; Estevez-Diz M; Irahara N; Donica M; Gonzalez-Martín A
Gynecol Oncol; 2020 Oct; 159(1):142-149. PubMed ID: 32763109
[TBL] [Abstract][Full Text] [Related]
10. A case report of endorectal displacement of a right ureteral stent following radiochemotherapy and Bevacizumab.
Tognarelli A; Faggioni L; Manassero F; Gadducci A; Selli C
BMC Urol; 2019 Dec; 19(1):128. PubMed ID: 31818277
[TBL] [Abstract][Full Text] [Related]
11. When a good call leads to a bad connection: colovesical fistula in colorectal cancer treated with bevacizumab.
Chen J; Smalligan RD; Nadesan S
Hosp Pract (1995); 2016 Aug; 44(3):120-2. PubMed ID: 27309405
[TBL] [Abstract][Full Text] [Related]
12. A rectovaginal fistula after treatment with bevacizumab. A dangerous side effect needing emergency treatment.
Galanopoulos M; Ladias S; Tzannetakou X; Tsigaridas A; Sarafis A; Liatsos C; Kalafatis E
Clin Case Rep; 2016 Apr; 4(4):449-50. PubMed ID: 27099749
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer - State of the science: From angiogenesis blockade to checkpoint inhibition.
Minion LE; Tewari KS
Gynecol Oncol; 2018 Mar; 148(3):609-621. PubMed ID: 29666026
[TBL] [Abstract][Full Text] [Related]
14. Phase I/II trial of bevacizumab and radiotherapy for locally advanced inoperable colorectal cancer: vasculature-independent radiosensitizing effect of bevacizumab.
Koukourakis MI; Giatromanolaki A; Sheldon H; Buffa FM; Kouklakis G; Ragoussis I; Sivridis E; Harris AL;
Clin Cancer Res; 2009 Nov; 15(22):7069-76. PubMed ID: 19887481
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal/genitourinary perforation and fistula formation with or without bevacizumab in patients with previously irradiated recurrent cervical cancer: a Korean multicenter retrospective study of the Gynecologic Oncology Research Investigators Collaboration (GORILLA) group (GORILLA-1001).
Hwang WY; Chang SJ; Kim HS; Kim NK; Kim TH; Kim Y; Kong TW; Lee EJ; Park SJ; Shim SH; Son JH; Suh DH; Yang EJ
BMC Cancer; 2022 Jun; 22(1):603. PubMed ID: 35655188
[TBL] [Abstract][Full Text] [Related]
16. Stromal vascular fraction injection to treat intractable radiation-induced rectovaginal fistula.
Kim M; Lew DH; Roh TS; Song SY
Arch Plast Surg; 2021 Jan; 48(1):127-130. PubMed ID: 33503756
[TBL] [Abstract][Full Text] [Related]
17. Radiation-induced rectovaginal fistulas in locally advanced gynaecological malignancies-new patients, old problem?
Zelga P; Tchórzewski M; Zelga M; Sobotkowski J; Dziki A
Langenbecks Arch Surg; 2017 Nov; 402(7):1079-1088. PubMed ID: 27987097
[TBL] [Abstract][Full Text] [Related]
18. Sigmoid-vaginal fistula during bevacizumab treatment diagnosed by fistulography.
Hayashi C; Takada S; Kasuga A; Shinya K; Watanabe M; Kano H; Takayama T
J Clin Pharm Ther; 2016 Dec; 41(6):725-726. PubMed ID: 27624676
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer.
Chuai Y; Rizzuto I; Zhang X; Li Y; Dai G; Otter SJ; Bharathan R; Stewart A; Wang A
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013348. PubMed ID: 33661538
[TBL] [Abstract][Full Text] [Related]
20. Improved survival with bevacizumab in advanced cervical cancer.
Tewari KS; Sill MW; Long HJ; Penson RT; Huang H; Ramondetta LM; Landrum LM; Oaknin A; Reid TJ; Leitao MM; Michael HE; Monk BJ
N Engl J Med; 2014 Feb; 370(8):734-43. PubMed ID: 24552320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
